Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Robin

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Blood|January 19, 2017
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelTheo de Witte, David Bowen, Marie Robin, et al.
Bone Marrow Transplantation|December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithmAlexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
Blood|May 10, 2024
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, et al.
Blood|March 27, 2025
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosisJuan Carlos Hernandez-Boluda, Adrian Mosquera Orgueira, Luuk Gras, et al.
American Journal of Hematology|February 22, 2024
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMTNicola Polverelli, Edouard F Bonneville, Liesbeth C de Wreede, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
Annales De Pathologie|August 16, 2021
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]Camille Franchet, Lounes Djerroudi, Aurélie Maran-Gonzalez, et al.
Experimental Hematology|July 9, 2013
Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registryHélène Labussière Wallet, Mohamad Sobh, Stéphane Morisset, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Blood|January 19, 2017
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panelTheo de Witte, David Bowen, Marie Robin, et al.
Bone Marrow Transplantation|December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithmAlexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
British Journal of Haematology|April 5, 2024
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMTFrancesco Onida, Luuk Gras, Junran Ge, et al.
Blood|May 10, 2024
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?Christof Scheid, Diderik-Jan Eikema, Michel van Gelder, et al.
Blood|March 27, 2025
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosisJuan Carlos Hernandez-Boluda, Adrian Mosquera Orgueira, Luuk Gras, et al.
American Journal of Hematology|February 22, 2024
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMTNicola Polverelli, Edouard F Bonneville, Liesbeth C de Wreede, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
Annales De Pathologie|August 16, 2021
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]Camille Franchet, Lounes Djerroudi, Aurélie Maran-Gonzalez, et al.
Experimental Hematology|July 9, 2013
Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registryHélène Labussière Wallet, Mohamad Sobh, Stéphane Morisset, et al.
Pageof 30